Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.650
+0.170 (6.85%)
At close: Mar 9, 2026, 4:00 PM EDT
2.670
+0.020 (0.75%)
After-hours: Mar 9, 2026, 5:51 PM EDT
CNTB Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0 | -2.02 | |
| Net Debt / Equity Ratio | -0.97 | -1.01 | -1.16 | -0.96 | -0.98 | -1.02 | |
| Net Debt / EBITDA Ratio | 0.99 | 4.29 | 1.72 | 1.32 | 2.75 | -5.48 | |
| Net Debt / FCF Ratio | 1.26 | 3.84 | 2.46 | 1.44 | 3.04 | -5.74 | |
| Asset Turnover | - | 0.23 | - | - | - | - | |
| Quick Ratio | 4.81 | 11.20 | 4.69 | 9.76 | 15.30 | 27.03 | |
| Current Ratio | 5.48 | 11.46 | 4.85 | 9.97 | 15.30 | 27.81 | |
| Return on Equity (ROE) | - | -16.14% | -47.96% | -54.96% | -364.72% | - | |
| Return on Assets (ROA) | - | -12.27% | -28.64% | -31.27% | -26.43% | -16.44% | |
| Return on Capital Employed (ROCE) | -99.00% | -24.20% | -67.60% | -73.50% | -35.80% | -18.30% | |
| Buyback Yield / Dilution | -0.57% | -0.27% | -0.04% | -5.50% | -205.31% | -1.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.